stoxline Quote Chart Rank Option Currency Glossary
  
IMARA Inc. (IMRA)
6.32  0.87 (15.96%)    02-23 16:00
Open: 5.21
High: 6.32
Volume: 271,721
  
Pre. Close: 5.45
Low: 5.18
Market Cap: 166(M)
Technical analysis
2023-03-03 4:50:22 PM
Short term     
Mid term     
Targets 6-month :  7.38 1-year :  8.62
Resists First :  6.32 Second :  7.38
Pivot price 5.3
Supports First :  4.82 Second :  3.9
MAs MA(5) :  5.49 MA(20) :  5.07
MA(100) :  4.25 MA(250) :  2.54
MACD MACD :  0.3 Signal :  0.2
%K %D K(14,3) :  87.2 D(3) :  81.4
RSI RSI(14): 75.3
52-week High :  6.32 Low :  0.97
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IMRA ] has closed Bollinger Bands are 9.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.32 - 6.34 6.34 - 6.36
Low: 5.13 - 5.15 5.15 - 5.17
Close: 6.27 - 6.31 6.31 - 6.35
Company Description

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Headline News

Tue, 06 Feb 2024
Imran Khan moved out of bungalow, sold Ferrari and left films to fix himself - Hindustan Times

Tue, 09 Jan 2024
Imran Khan, mom Nuzhat, daughter Imara, rumoured girlfriend Lekha Washington feature in family portrait at Ira Khan-Nupur Shikhare’s mehendi. See - The Indian Express

Wed, 22 Feb 2023
Imara Announces Stockholder Approval of Merger With Enliven - GlobeNewswire

Fri, 06 Jan 2023
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch - Penny Stocks

Thu, 10 Nov 2022
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, KNBE, IMRA, AGFS - AccessWire

Thu, 13 Oct 2022
Enliven Therapeutics and Imara Announce Merger Agreement - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 26 (M)
Shares Float 9 (M)
Held by Insiders 16.6 (%)
Held by Institutions 71.3 (%)
Shares Short 341 (K)
Shares Short P.Month 1,370 (K)
Stock Financials
EPS -2.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.77
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -34.2 %
Return on Equity (ttm) -57.5 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.71
Qtrly Earnings Growth 0 %
Operating Cash Flow -46 (M)
Levered Free Cash Flow -30 (M)
Stock Valuations
PE Ratio -2.54
PEG Ratio 0
Price to Book value 1.67
Price to Sales 0
Price to Cash Flow -3.6
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android